Ningdong Granule Upregulates the Striatal DA Transporter and Attenuates Stereotyped Behavior of Tourette Syndrome in Rats.


Journal

Evidence-based complementary and alternative medicine : eCAM
ISSN: 1741-427X
Titre abrégé: Evid Based Complement Alternat Med
Pays: United States
ID NLM: 101215021

Informations de publication

Date de publication:
2020
Historique:
received: 20 03 2020
revised: 15 08 2020
accepted: 28 08 2020
entrez: 2 10 2020
pubmed: 3 10 2020
medline: 3 10 2020
Statut: epublish

Résumé

This study aimed to evaluate the possible mechanism of Ningdong granule (NDG) for the treatment of Tourette syndrome (TS). The rats with stereotyped behavior were established by microinjection with TS patients' sera; then, the model rats were divided into NDG and haloperidol (Hal) group, and the nonmedication model rats were regarded as treatment control (TS group). The stereotyped behavior of the rats was recorded, the level of dopamine (DA) in striatum, and the content of homovanillic acid (HVA) in sera were tested, and dopamine transporter (DAT) expression was measured in the study. The experimental results showed that NDG effectively inhibited the stereotyped behavior (

Identifiants

pubmed: 33005197
doi: 10.1155/2020/2980705
pmc: PMC7509575
doi:

Types de publication

Journal Article

Langues

eng

Pagination

2980705

Informations de copyright

Copyright © 2020 Jijun Li et al.

Déclaration de conflit d'intérêts

The authors declare that they have no conflicts of interest.

Références

Psychiatry Res. 2008 Feb 28;162(2):159-66
pubmed: 18248965
Psychiatry Res. 2007 Jan 15;149(1-3):297-302
pubmed: 17113158
Biosci Trends. 2012 Aug;6(4):212-8
pubmed: 23006968
Neurosci Biobehav Rev. 2013 Jul;37(6):997-1007
pubmed: 23206664
CNS Drugs. 2018 Jan;32(1):33-45
pubmed: 29335879
Evid Based Complement Alternat Med. 2013;2013:385685
pubmed: 23431337
Chin J Integr Med. 2009 Aug;15(4):261-5
pubmed: 19688313
Brain Dev. 2003 Dec;25 Suppl 1:S70-84
pubmed: 14980376
Mol Med Rep. 2019 Jul;20(1):191-197
pubmed: 31115527
J Psychosom Res. 2009 Dec;67(6):475-83
pubmed: 19913651
J Tradit Chin Med. 2012 Jun;32(2):283-8
pubmed: 22876458
World J Biol Psychiatry. 2008;9(1):76-7
pubmed: 17853302
Methods. 2001 Dec;25(4):402-8
pubmed: 11846609
Sci Rep. 2015 Jan 16;5:7731
pubmed: 25592875
J Child Adolesc Psychopharmacol. 2006 Aug;16(4):505-6
pubmed: 16958578
Eur Neuropsychopharmacol. 2014 Dec;24(12):1896-906
pubmed: 25464894
Neuropsychopharmacology. 2008 May;33(6):1239-51
pubmed: 17987065
J Neurol. 2006 Jan;253(1):1-15
pubmed: 16331353
Pharmacol Biochem Behav. 2005 Aug;81(4):879-86
pubmed: 16045972
Eur J Pharmacol. 2003 Oct 31;479(1-3):139-52
pubmed: 14612145
Behav Brain Res. 2008 Jan 10;186(1):84-90
pubmed: 17850895
J Ethnopharmacol. 2009 Jul 30;124(3):488-92
pubmed: 19467315
Medicine (Baltimore). 1991 Jan;70(1):15-32
pubmed: 1988764
Eur J Pharmacol. 2003 Oct 31;479(1-3):153-8
pubmed: 14612146
Handb Exp Pharmacol. 2017;241:189-215
pubmed: 28233179
Lancet. 2002 Nov 16;360(9345):1577-86
pubmed: 12443611
Neurol India. 2010 Jul-Aug;58(4):523-9
pubmed: 20739786
Mov Disord. 2018 Feb;33(2):238-242
pubmed: 29278288
Neuroimage Clin. 2017 Aug 03;16:257-267
pubmed: 28831377
Cell Mol Life Sci. 2004 Apr;61(7-8):886-98
pubmed: 15095010
Prog Neuropsychopharmacol Biol Psychiatry. 2007 Oct 1;31(7):1478-86
pubmed: 17669571
Am J Psychiatry. 2002 Apr;159(4):657-60
pubmed: 11925307
Zhongguo Zhong Xi Yi Jie He Za Zhi. 2013 Aug;33(8):1112-5
pubmed: 24325065
J Int Med Res. 2010 Jan-Feb;38(1):169-75
pubmed: 20233526
Brain Res Bull. 2007 Sep 14;74(1-3):58-65
pubmed: 17683790
Zhongguo Zhong Xi Yi Jie He Za Zhi. 2014 Apr;34(4):435-8
pubmed: 24812899
J Child Neurol. 2013 Nov;28(11):1406-1411
pubmed: 23329584
Toxicol Lett. 2015 Jul 2;236(1):60-8
pubmed: 25943760
Adv Neurol. 2001;85:163-78
pubmed: 11530426
Brain Res Bull. 1983 Aug;11(2):205-8
pubmed: 6578865
J Child Adolesc Psychopharmacol. 2010 Aug;20(4):317-31
pubmed: 20807070
PLoS One. 2012;7(7):e41623
pubmed: 22911828
Eur Child Adolesc Psychiatry. 2013 Feb;22 Suppl 1:S55-60
pubmed: 23224240
Brain Res. 2015 Aug 18;1617:126-43
pubmed: 24845720
J Psychosom Res. 2003 Jul;55(1):41-8
pubmed: 12842230
Semin Pediatr Neurol. 2010 Dec;17(4):254-60
pubmed: 21183132

Auteurs

Jijun Li (J)

Department of Integrative Medicine on Pediatrics, Shanghai Children's Medical Center, Shanghai Jiao Tong University School of Medicine, Shanghai 200127, China.

Yi Guo (Y)

Department of Neurology, Shenzhen People's Hospital, The Second Clinical Medical College of Jinan University, The First Affiiated Hospital of Southern University of Science and Technology, Shenzhen 518020, China.

Lin Zhao (L)

Department of Integrative Medicine on Pediatrics, Provincial Hospital Affiliated to Shandong University, Jinan, Shandong 250021, China.

Kexing Sun (K)

Department of Integrative Medicine on Pediatrics, Shanghai Children's Medical Center, Shanghai Jiao Tong University School of Medicine, Shanghai 200127, China.

Guangjun Xi (G)

Department of Neurology, Wuxi People's Hospital of Nanjing Medical University, Wuxi 214023, China.

Zai-Wang Li (ZW)

Department of Neurology, Shenzhen People's Hospital, The Second Clinical Medical College of Jinan University, The First Affiiated Hospital of Southern University of Science and Technology, Shenzhen 518020, China.

Classifications MeSH